Literature DB >> 9707101

QSAR models for discriminating between mutagenic and nonmutagenic aromatic and heteroaromatic amines.

R Benigni1, L Passerini, G Gallo, F Giorgi, M Cotta-Ramusino.   

Abstract

In a previous article, we demonstrated that the structure-activity relationship model for the mutagenic potency of aromatic amines is different from that for discriminating between mutagens and nonmutagens. In this work, we present further analyses on the molecular determinants of the mutagenicity of aromatic amines. Based on the use of various methodological approaches, our results indicate that mutagenic activity is influenced by different molecular characteristics in different subclasses of aromatic amines. Thus, the general lesson of this article is that 1) in genetic toxicology, it is necessary to separately investigate the structure-activity relationships for discrimination between positive and negative chemicals, and the structure-activity relationships for the potency of the positive chemicals; 2) in structure-activity studies, it is necessary to investigate the degree of homogeneity (congenericity) of apparently similar chemicals in order to assess and describe the various mechanisms of action that may be elicited by the chemicals.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9707101     DOI: 10.1002/(sici)1098-2280(1998)32:1<75::aid-em9>3.0.co;2-a

Source DB:  PubMed          Journal:  Environ Mol Mutagen        ISSN: 0893-6692            Impact factor:   3.216


  4 in total

1.  Towards a new age of virtual ADME/TOX and multidimensional drug discovery.

Authors:  Sean Ekins; Bruno Boulanger; Peter W Swaan; Maggie A Z Hupcey
Journal:  J Comput Aided Mol Des       Date:  2002 May-Jun       Impact factor: 3.686

2.  Aryl Piperazinyl Ureas as Inhibitors of Fatty Acid Amide Hydrolase (FAAH) in Rat, Dog, and Primate.

Authors:  John M Keith; Rich Apodaca; Mark Tichenor; Wei Xiao; William Jones; Joan Pierce; Mark Seierstad; James Palmer; Michael Webb; Mark Karbarz; Brian Scott; Sandy Wilson; Lin Luo; Michelle Wennerholm; Leon Chang; Sean Brown; Michele Rizzolio; Raymond Rynberg; Sandra Chaplan; J Guy Breitenbucher
Journal:  ACS Med Chem Lett       Date:  2012-08-22       Impact factor: 4.345

Review 3.  Towards a new age of virtual ADME/TOX and multidimensional drug discovery.

Authors:  Sean Ekins; Bruno Boulanger; Peter W Swaan; Maggie A Z Hupcey
Journal:  Mol Divers       Date:  2002       Impact factor: 2.943

4.  An investigation into pharmaceutically relevant mutagenicity data and the influence on Ames predictive potential.

Authors:  Patrick McCarren; Clayton Springer; Lewis Whitehead
Journal:  J Cheminform       Date:  2011-11-22       Impact factor: 5.514

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.